Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
about
The Role of PPARs in CancerThe human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactionsSelective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription.PPARdelta regulates glucose metabolism and insulin sensitivityPPAR delta: a dagger in the heart of the metabolic syndrome.Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fastingIntegrated physiology and systems biology of PPARαFatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleusLipoexpediency: de novo lipogenesis as a metabolic signal transmitterPPARs and the cardiovascular systemIdentification of a physiologically relevant endogenous ligand for PPARalpha in liverIn vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolismAdvances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and diseaseAssociation of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: a Go-DARTS studyDual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.A general introduction to the biochemistry of mitochondrial fatty acid β-oxidationPeroxisome Proliferator-Activated Receptors in Female Reproduction and FertilityModulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat DietsN-3 Polyunsaturated Fatty Acids and Inflammation in Obesity: Local Effect and Systemic BenefitMechanisms of gene regulation by fatty acidsThe case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathyPeroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a reviewStructural basis for the activation of PPARgamma by oxidized fatty acidsStructural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor / AgonistPPARγ as a therapeutic target to rescue mitochondrial function in neurological diseaseAntidiabetic Properties, Bioactive Constituents, and Other Therapeutic Effects of Scoparia dulcisFatty-acyl-CoA thioesters inhibit recruitment of steroid receptor co-activator 1 to alpha and gamma isoforms of peroxisome-proliferator-activated receptors by competing with agonistsLong-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathwayDifferential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestineInhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-IAn update of the defensive barrier function of skinDifferentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/deltaPPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunctionLoss of the acyl-CoA binding protein (Acbp) results in fatty acid metabolism abnormalities in mouse hair and skinThe impact of PPARα activation on whole genome gene expression in human precision cut liver slicesActivation of protein kinase A and exchange protein directly activated by cAMP promotes adipocyte differentiation of human mesenchymal stem cellsThe effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth.Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults.
P2860
Q21342955-60A9A21B-46C0-4590-9530-0AB20FEE81BBQ24310512-F0E0BBE4-A720-402E-B7C0-2E917F8907C3Q24540092-A5985512-EF80-4BB2-A6AC-BCA3F79CDF2DQ24541495-22480EA5-098E-43A6-BB88-BE367D4ED680Q24541527-FCB828DC-1C01-43B2-9E0D-94878122B692Q24553125-8B85B418-8A3A-4FE9-9C67-6A242C15232BQ24563197-96907556-8CE1-4C52-8F34-B76AA067632FQ24564130-2FD6A110-BE8F-491E-A921-2D77AF4B921EQ24612974-7A608392-A146-4B90-98FE-411864B49C17Q24620189-BF6758A0-1EF0-4ABC-972D-98F14BB9B1C2Q24642728-5C069F4A-B2AE-48D2-8850-F1F23B0F136DQ24653691-E6B494A3-3347-4F25-AD50-68A55BE6C08DQ24675720-B9F1039F-067F-4E2C-9F28-AB22F127A3B0Q24803926-AA0C3057-4044-4F55-9FB0-42263BFCE2E0Q24813954-5048003E-029E-4A8E-8EBB-360459E3A0EEQ24816834-7470A0BB-D145-4A8D-9496-4C09E9A09869Q26699142-AD07E153-6CDB-49A0-A162-6B459487ACC3Q26738962-CF827789-365C-4BC8-8EF8-3A42685A4E91Q26745587-C23E33AD-5A1F-4497-82B2-159717DF9BBCQ26784504-3F40ADD5-211B-4B65-B8D3-62E002D4C96DQ26863658-7E8E2CEA-200C-41E7-AA44-141A9E149856Q26865958-2D619A5B-A843-4A31-8022-FB5C41B66A51Q26866784-1C871756-51DD-4562-B4C9-5B06A90AD72DQ27653525-54E0C9EA-99A2-4EED-87B0-2D4952CD1414Q27670895-6CBB6E9D-BCC0-4F5F-94D5-36569B5744B5Q28069549-8D9A1B6F-2BA8-43AC-BFD8-A0D1148CFCE0Q28069630-5F43671B-B780-4AA3-BB1E-8A6D9841C43BQ28345513-FFF576E9-27D0-43CC-B2AD-8339B2FA1D25Q28348167-D0F0CADE-FA8B-4470-8369-52E813922266Q28361841-90F6647D-FDA5-449A-A8DF-A342266B2604Q28366307-0137D362-15F7-4472-9739-EB6600F9B228Q28366335-77F1AEEF-59EE-4B42-9E4B-C9D6C5E0E6F2Q28468651-320C9315-9E5A-45E9-A92D-49F0BD5F89A7Q28504818-637F09B5-664D-435A-B2B5-2D334E500ABFQ28574319-7ECCAE50-6D81-4ABA-9AD2-94F2F530DC31Q28588458-8A4BB804-B79B-4402-9B1D-EE8ED1031A85Q28606579-38D819D9-A24A-4A2B-BED3-390E68D7E9B3Q28730910-4361DCD9-EDF5-4DB4-A610-EE18DFDF91C4Q30434996-66AE87DF-4103-425A-9EE5-C11670467A97Q30500249-B230E984-D83B-4EE9-B089-FCA4DC08113E
P2860
Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Fatty acids, eicosanoids, and ...... pendent receptor ligand assay.
@en
Fatty acids, eicosanoids, and ...... pendent receptor ligand assay.
@nl
type
label
Fatty acids, eicosanoids, and ...... pendent receptor ligand assay.
@en
Fatty acids, eicosanoids, and ...... pendent receptor ligand assay.
@nl
prefLabel
Fatty acids, eicosanoids, and ...... pendent receptor ligand assay.
@en
Fatty acids, eicosanoids, and ...... pendent receptor ligand assay.
@nl
P2093
P356
P1476
Fatty acids, eicosanoids, and ...... pendent receptor ligand assay.
@en
P2093
Braissant O
Kalkhoven E
L'Horset F
P304
P356
10.1210/MEND.11.6.0007
P577
1997-06-01T00:00:00Z